RxPreferred Benefits Expands Executive Leadership Team with Strategic Appointment and Key Promotions

About this update from Myriad Genetics, Inc.

NASHVILLE, Tenn. , Aug. 12, 2025 /PRNewswire/ -- RxPreferred Benefits, a leading transparent pharmacy benefit administrator, today announced the strategic expansion of its executive leadership team with the appointment of a new senior executive and the promotion of two accomplished leaders. These changes underscore the company's commitment to innovation, operational excellence, and sustainable growth. Strategic Appointment: Chief Growth Officer RxPreferred has appointed Greg Abram as Chief Growth Officer. With over 15 years of executive leadership experience in healthcare and pharmacy benefit management (PBM), Abram has a proven record of driving revenue growth, building strategic partnerships, and delivering exceptional client outcomes. His career includes leadership roles at Xevant, Myriad Genetics, Navitus Health, and OptumRx. "We're thrilled to welcome Greg to the team," said Jeff Malone , President and CEO of RxPreferred Benefits. "His industry expertise and forward-thinking approach align perfectly with our mission to lead with transparency and innovation. Greg's leadership will be instrumental as we continue expanding our impact across the healthcare landscape." Key Promotions: Strengthening Technology and Compliance Leadership The company also announced the promotion of two valued team members: "These promotions reflect our deep appreciation for Keith and Phillip's contributions," added Malone. "Their leadership, integrity, and commitment to our mission have been central to our progress, and we are confident they will continue to drive meaningful results in their expanded roles." This strategic leadership expansion reinforces RxPreferred's dedication to delivering nationwide transparent, innovative, and client-focused pharmacy benefit solutions for plan sponsors. About RxPreferred RxPreferred is an independent, technology-driven administrator specializing in Pharmacy Benefit Administration, 340B programs, and Pharmaceutical Rebates. Leveraging real-time data analytics and proactive cost-containment strategies, the company delivers transparent, customized solutions that enable plan sponsors to achieve maximum savings and enhanced clinical value across the pharmacy benefit spectrum. View original content to download multimedia: https://www.prnewswire.com/news-releases/rxpreferred-benefits-expands-executive-leadership-team-with-strategic-appointment-and-key-promotions-302527744.html SOURCE RxPreferred

View stock analysis, news, and events for Myriad Genetics, Inc.